Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer
NCT02381912 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 210
Last updated 2016-03-09
Summary
The purpose of the study is to investigate sexual function in patients suspected of non muscle invasive bladder cancer (NMIBC). The investigators hypothesis is that reduced sexual function is underdiagnosed in patients with non-muscle invasive bladder cancer and that active examination and treatment may worsen the sexual function.
Conditions
- Urinary Bladder Neoplasms
- Sexual Dysfunction, Physiological
- Sexual Dysfunctions, Psychological
- Erectile Dysfunction
- Hematuria
Interventions
- OTHER
-
EORTC QLQ-C30 and EORTC BLS-24 questionnaire
Questionnaires answered at baseline and 4 months follow up.
Sponsors & Collaborators
-
Herlev Hospital
lead OTHER
Principal Investigators
-
Peter B Østergren, MD · Herlev Hospital, Department of Urology
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer
NCT04726735 ·Status: COMPLETED
-
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
NCT06488222 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy
NCT04943094 ·Status: ACTIVE_NOT_RECRUITING
-
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
NCT06350734 ·Status: ACTIVE_NOT_RECRUITING
-
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
NCT05223491 ·Status: COMPLETED ·Phase: NA
-
Sexual Quality of Patients After Bladder Cancer Cystectomy
NCT04964895 ·Status: COMPLETED
-
Health-Related Quality of Life in Patients With Bladder Cancer
NCT00744744 ·Status: COMPLETED
-
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
NCT04144270 ·Status: UNKNOWN
-
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
NCT05739968 ·Status: RECRUITING ·Phase: NA
-
To Better Understand the Most Important Factors for Patients When They Decide on the Type of Treatment They Receive for Muscle Invasive Bladder Cancer (MIBC).
NCT05236218 ·Status: UNKNOWN
-
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
NCT07225127 ·Status: RECRUITING
-
Quality of Life in Patients With Bladder Cancer
NCT00745355 ·Status: ACTIVE_NOT_RECRUITING
-
Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NCT07180212 ·Status: RECRUITING ·Phase: NA
-
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 ·Status: UNKNOWN
-
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
NCT02845323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
NCT00872495 ·Status: RECRUITING
-
Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
NCT02298998 ·Status: COMPLETED
-
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC
NCT06253845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
NCT05195515 ·Status: ENROLLING_BY_INVITATION
-
An Educational Intervention for Patients With Bladder Cancer
NCT01915121 ·Status: COMPLETED ·Phase: NA
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
NCT02186925 ·Status: UNKNOWN
-
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
NCT02203136 ·Status: COMPLETED
-
An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT05356351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2